National Service Hotline:+86756-8666883

-News-

NEWS INFORMATION

All
  • All
  • Product Management
  • News
  • Introduction
  • Enterprise outlets
  • FAQ
  • Enterprise Video
  • Enterprise Atlas

China Chengtong "Three Importants and One Major" Decision System Online Training Meeting Successfully Held

2023/08/31

From July 25 to 26, the on-line training meeting of China Chengtong's "Three Importants and One Major" decision-making system was held in Beijing. This training was undertaken by China Paper. Zhu Xiaozheng, Director of the Group's President's Office and Deputy Secretary of the Party Committee of China Paper, made the opening mobilization.

The meeting pointed out that it is necessary to improve the position, clarify the rights and responsibilities and working methods of the party organization in decision-making, implementation, and supervision. The party committee's gatekeeping orientation should be coordinated with the scientific decision-making of the board of directors and managers, and the "three important and one large" decision-making process should be standardized. It is necessary to clarify the scientific and democratic decision-making of major issues in the construction of the "three important and one large" system, realize the comprehensive supervision of the "three important and one large" issues, improve the efficiency of supervision, and improve the decision-making awareness of decision-makers in accordance with laws and regulations. It is necessary to enhance the ability to operate the "three important and one large" system through training, and complete the task of decision-making and operation supervision system construction with quality and quantity.

More than 70 people participated in the training from 8 units including China Paper, Chengtong Hong Kong, Chengtong Manpower, China Packaging, China Business Group, Chengtong Fund, Chengtong Real Estate and Chengyang Investment.

Related News

28

2023/09

祝贺!福建省药品审评与监测评价中心实训基地在大博医疗正式授牌

2023年9月15日,福建省药品审评与监测评价中心实训基地签约及授牌仪式在大博医疗科技股份有限公司(以下简称“大博医疗”)举行。国家药监局药品评价中心器械二部部长董放、专家郑立佳,省药品审评中心主任李宗、科长沈晓华,厦门市审评监测中心主任李剑青等一行,以及大博医疗董事长林志雄、轮值主席陈又存和副总经理卢忠炜等出席本次签约及授牌仪式。

28

2023/09

中国医疗器械行业协会外科植入物专业委员会第十八届年会在深圳召开

中国医疗器械行业协会外科植入物专业委员会第十八届年会在深圳召开

28

2023/09

福建省卫健委党组书记、主任杨闽红带队莅临大博医疗参观调研

福建省卫健委党组书记、主任杨闽红带队莅临大博医疗参观调研